Proteome Sciences (LON:PRM) Posts Earnings Results

Proteome Sciences (LON:PRM) posted its quarterly earnings results on Wednesday. The company reported GBX (0.41) earnings per share (EPS) for the quarter, Digital Look Earnings reports. Proteome Sciences had a negative net margin of 81.50% and a positive return on equity of 33.80%.

Proteome Sciences Stock Down 16.6%

Proteome Sciences stock traded down GBX 0.24 on Thursday, hitting GBX 1.21. 5,279,079 shares of the stock traded hands, compared to its average volume of 402,580. The business’s fifty day simple moving average is GBX 1.71 and its 200 day simple moving average is GBX 1.64. Proteome Sciences has a 1 year low of GBX 1.11 and a 1 year high of GBX 4.40. The firm has a market cap of £4.24 million, a P/E ratio of -1.16 and a beta of 0.16. The company has a current ratio of 0.13, a quick ratio of 0.37 and a debt-to-equity ratio of -165.46.

Proteome Sciences Company Profile

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.